Stock comparison
Jeena Sikho Lifecare Limited
JSLL.BO$70.32BHealthcare Market cap, Sector
BeOne Medicines
ONC$32.37BHealthcare Market cap, Sector
Overall winner
Jeena Sikho Lifecare Limited
JSLL.BO 61 ONC
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
JSLL.BO6wins
1winsONC
84B
D56
87A
C69
92A
B78
66C
C69
75B
F43
91A
D50
95A
D54
Side-by-side metrics
| Metric | JSLL.BO | ONC |
|---|---|---|
| Market cap | Winner: $70.32B | $32.37B |
| P/E (TTM) | Winner: 33.2x | 107.5x |
| EV/EBIT | Winner: 24.1x | 28.9x |
| ROIC (TTM) | Winner: 39.15% | 7.73% |
| Gross margin | Winner: 88.58% | 87.17% |
| Net margin | Winner: 27.68% | 8.93% |
| Revenue CAGR 5y | Winner: 57.81% | 45.99% |
| EPS CAGR 5y | Winner: 86.67% | 67.36% |
| Debt / Equity | Winner: 0.3x | 0.4x |
| Dividend yield | - | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
JSLL.BO leads on
- ROIC (TTM)39.15%vs 7.73%+80%
- P/E (TTM)33.2xvs 107.5x+69%
- Net margin27.68%vs 8.93%+68%
- Market cap$70.32Bvs $32.37B+54%
ONC leads on
No clear edges - the other side wins or ties on every measured metric.
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.